Samsung C&T

028260 · KOSPI · Industrials · LARGE CAP

Updated terms.

Samsung C&T updated the disclosed terms of a subsidiary's acquisition of PolyPeptide Group AG, now worth US$1.96B.

M&A([Amended] Decision to acquire shares/equity in another company (subsidiary))· FILED 2026-08-28· RCEPT 20260828800834

US$1.96BDeal value
3.1%vs. company assets

Converted at 1 USD ≈ ₩1,380.45 (filing-date rate, 2026-08-27 close)

A later amendment corrects this filing, so the terms on this page may be out of date. See the latest version (2026-10-16) →

What happened

Samsung C&T updated the disclosed terms of a subsidiary's acquisition of PolyPeptide Group AG, now worth US$1.96B.

For context, this deal is worth about 3.1% of the company's consolidated total assets.

TargetPolyPeptide Group AG
Deal valueUS$1.96B
vs. company assets3.1%
Filed2026-08-28, [Amended] Decision to acquire shares/equity in another company (subsidiary)
SourceDART rcept 20260828800834 → open original filing

Versions of this filing

  1. 2026-07-20Original
  2. 2026-08-28Amendment 1 (this page)
  3. 2026-10-16Amendment 2

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-08-28 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.